Authors:
Cushman, WC
Materson, BJ
Williams, DW
Reda, DJ
Citation: Wc. Cushman et al., Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial, HYPERTENSIO, 38(4), 2001, pp. 953-957
Authors:
Grimm, RH
Margolis, KL
Papademetriou, V
Cushman, WC
Ford, CE
Bettencourt, J
Alderman, MH
Basile, JN
Black, HR
DeQuattro, V
Eckfeldt, J
Hawkins, CM
Perry, HM
Proschan, M
Citation: Rh. Grimm et al., Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT), HYPERTENSIO, 37(1), 2001, pp. 19-27
Authors:
Wurtzbacher, JD
Gourley, GA
Cushman, WC
Fine, D
Miller, J
Shane, R
Schultz, K
Citation: Jd. Wurtzbacher et al., Case 4: Systolic hypertension; Diabetes mellitus; Renal dysfunction; and the use of ACE inhibitors in African-American population - Level 3, AM J M CARE, 6(3), 2000, pp. S141
Authors:
Wurtzbacher, JD
Gourley, GA
Cushman, WC
Fine, D
Miller, J
Shane, R
Schultz, K
Citation: Jd. Wurtzbacher et al., Case 5: Congestive heart failure; Prior myocardial infarction; Economic considerations of care in Medicare population - Level 3, AM J M CARE, 6(3), 2000, pp. S144
Authors:
Franse, LV
Pahor, M
Di Bari, M
Somes, GW
Cushman, WC
Applegate, WB
Citation: Lv. Franse et al., Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program, HYPERTENSIO, 35(5), 2000, pp. 1025-1030
Citation: Wc. Cushman, Systolic blood pressure, diastolic blood pressure, or pulse pressure: Which is more important for the practicing clinician?, SOUTH MED J, 93(5), 2000, pp. 531-533
Authors:
Cushman, WC
Reda, DJ
Perry, HM
Williams, D
Abdellatif, M
Materson, BJ
Citation: Wc. Cushman et al., Regional and racial differences in response to antihypertensive medicationuse in a randomized controlled trial of men with hypertension in the United States, ARCH IN MED, 160(6), 2000, pp. 825-831
Authors:
Lakshman, MR
Reda, DJ
Materson, BJ
Cushman, WC
Freis, ED
Citation: Mr. Lakshman et al., Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension, ARCH IN MED, 159(6), 1999, pp. 551-558
Citation: Wc. Cushman et E. Hanna, Failure of alcohol reduction to lower blood pressure in the PATHS trial - In reply, ARCH IN MED, 159(2), 1999, pp. 195-196
Authors:
Somes, GW
Pahor, M
Shorr, RI
Cushman, WC
Applegate, WB
Citation: Gw. Somes et al., The role of diastolic blood pressure when treating isolated systolic hypertension, ARCH IN MED, 159(17), 1999, pp. 2004-2009